Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Day One Biopharmaceuticals (DAWN) Shares Outstanding (Diluted Average): 2022-2025

Historic Shares Outstanding (Diluted Average) for Day One Biopharmaceuticals (DAWN) over the last 4 years, with Sep 2025 value amounting to $103.4 million.

  • Day One Biopharmaceuticals' Shares Outstanding (Diluted Average) rose 6.65% to $103.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.4 million, marking a year-over-year increase of 6.65%. This contributed to the annual value of $93.2 million for FY2024, which is 16.87% up from last year.
  • As of Q3 2025, Day One Biopharmaceuticals' Shares Outstanding (Diluted Average) stood at $103.4 million, which was up 0.30% from $103.1 million recorded in Q2 2025.
  • In the past 5 years, Day One Biopharmaceuticals' Shares Outstanding (Diluted Average) ranged from a high of $103.4 million in Q3 2025 and a low of $58.4 million during Q1 2022.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $87.1 million (2024), whereas its average is $89.6 million.
  • Data for Day One Biopharmaceuticals' Shares Outstanding (Diluted Average) shows a peak YoY climbed of 23.38% (in 2023) over the last 5 years.
  • Day One Biopharmaceuticals' Shares Outstanding (Diluted Average) (Quarterly) stood at $65.5 million in 2022, then climbed by 21.85% to $79.8 million in 2023, then rose by 16.87% to $93.2 million in 2024, then grew by 6.65% to $103.4 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $103.4 million in Q3 2025, compared to $103.1 million in Q2 2025 and $102.7 million in Q1 2025.